Every year, in conjunction with the R&D 100 Awards Banquet, R&D Magazine’s editors convene a panel of R&D leaders to discuss the current issues confronting their organization’s R&D programs, staff and administration. This year’s panel was held on November 7, 2014, at the Bellagio, Las Vegas, Nev., and included three R&D managers from industry and one each from government and academic organizations.
Sandia National Laboratories is tackling one of the biggest barriers to the use of robots in...
Earlier this month, the NTSB released its...
Sandia National Laboratories is studying how environments, including radiation that originates from a nuclear weapon itself, could affect the performance of electronics in the W76-1 warhead as they age. Sandia is helping replace W76 warheads in the U.S. stockpile with a refurbished version under the W76-1 Life Extension Program (LEP). The ballistic missile warhead is carried on the Trident II D5 missile aboard Ohio-class Navy submarines.
The White House says the Obama administration is making strides in the fight against Ebola, citing an expanded hospital network and testing capacity at home and gains confronting the deadly disease in West Africa. To sustain that, President Barack Obama was prodding Congress Tuesday to approve his request for $6.2 billion in emergency spending against the outbreak.
Lawrence Livermore National Laboratory and the RAND Corporation will collaborate to expand the use of high-performance computing in decision analysis and policymaking. The two organizations signed a memorandum of understanding on Friday, Nov. 21. The arrangement provides a vehicle for the two organizations to explore the use of policy analysis methodologies with supercomputing applications.
The next Ebola or the next SARS. Maybe even the next HIV. Even before the Ebola epidemic in West Africa is brought under control, public health officials are girding for the next health disaster. Ebola sprang from one of those blind spots, in an area that lacks the health systems needed to detect an outbreak before it becomes a crisis.
U.S. government health regulators on Thursday approved the first hard-to-abuse version of the painkiller hydrocodone, offering an alternative to a similar medication that has been widely criticized for lacking such safeguards. The FDA approved Purdue Pharma's Hysingla ER for patients with severe, round-the-clock pain that cannot be managed with other treatments.
Mark Hart, a scientist and engineer at Lawrence Livermore National Laboratory, has been awarded the 2015 Surety Transformation Initiative (STI) Award from the National Nuclear Security Administration’s Enhanced Surety Program. The STI award aims to stimulate and encourage the development of potentially transformational nuclear weapon surety technologies and explore innovative, preferably monumental shift solutions, to unmet surety needs.
Argonne National Laboratory has announced a new intellectual property licensing agreement with AKHAN Semiconductor, continuing a productive public-private partnership that will bring diamond-based semiconductor technologies to market. The agreement gives AKHAN exclusive rights to a suite of breakthrough diamond-based semiconductor inventions developed by nanoscientist Ani Sumant of Argonne’s Center for Nanoscale Materials.
The government proposed new rules Wednesday to make it easier for doctors and patients to learn if clinical trials of treatments worked or not. Thousands of Americans participate in clinical trials every year, testing new treatments, comparing old ones or helping to uncover general knowledge about health. Many of the studies are reported in scientific journals and trumpeted in the news.
The world still isn't close to preventing what leaders call a dangerous level of man-made warming, a new United Nations report says. That's despite some nations' recent pledges to cut back on carbon dioxide emissions. The report looks at the gap between what countries promise to do about carbon pollution and what scientists say needs to be done to prevent temperatures rising another two degrees.
Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now. A large study found that continuing for another 18 months lowers the risk of heart attacks, clots and other problems. Even quitting after 30 months made a heart attack more likely, raising a question of when it's ever safe to stop.
Nanomedicine is offering patients a growing arsenal of therapeutic drugs for a variety of diseases, but often at a cost of thousands of dollars a month. Generics could substantially reduce the price tag for patients—if only there were a well-defined way to make and regulate them. An article in Chemical & Engineering News (C&EN) details the challenges on the road to generic nanodrugs.
Squeezed R&D budgets in the EU, Japan and U.S. are reducing the weight of advanced economies in science and technology research, patent applications and scientific publications and leaving China on track to be the world’s top R&D spender by around 2019, according to a OECD report.
Health workers on the front line of the Ebola crisis say the need for urgent help isn't letting up, as Congress begins considering President Barack Obama's $6.2 billion emergency aid request to fight the disease. Despite reports that the number of infections is slowing in some parts of West Africa, cases still are rising in other areas.
Medicare may soon begin paying for yearly scans to detect lung cancer in certain current or former heavy smokers. The Centers for Medicare and Medicaid Services on Monday issued a long-awaited proposal to begin covering the screening for high-risk beneficiaries if their doctors agree they meet the criteria.
Dr. Robert Fuller didn't hesitate to go to Indonesia to treat survivors of the 2004 tsunami, to Haiti to help after the 2010 earthquake or to the Philippines after a devastating typhoon last year. But he's given up on going to West Africa to care for Ebola patients this winter. He could make the six-week commitment sought by his go-to aid organization, International Medical Corps.
Here is an idea worth following: “share” for tenure; “like” to get cited. Academic researchers are turning to social media more and more, according to new research.
Researchers at Sandia National Laboratories have received a $1.2 million award from the U.S. Dept. of Energy’s SunShot Initiative to develop a technique that they believe will significantly improve the efficiencies of photovoltaic materials and help make solar electricity cost-competitive with other sources of energy.
French security officials are investigating a spate of mysterious and illegal flights by drone aircraft over more than a dozen nuclear power stations in France, raising security concerns in a country that largely lives off atomic energy. In what environmental activists call a worrisome development, authorities have tallied at least 15 overflights of nuclear sites since early October, culminating Friday with five at separate sites.
Yale Univ. engineer Jan Schroers will lead a three-year, $1.2 million project intended to dramatically accelerate the pace of discovering and characterizing bulk metallic glasses (BMGs), a versatile type of pliable glass that’s stronger than steel. The grant will enable Schroers’ team to screen more than 3,000 potential BMG alloys in a week, a vast improvement over traditional methods.
Top medical experts studying the spread of Ebola say the public should expect more cases to emerge in the U.S. by year's end as infected people arrive here from West Africa, including American doctors and nurses returning from the hot zone and people fleeing from the deadly disease. But how many cases?
In spite of the broad scientific consensus about its existence, global warming remains a contentious public policy issue. Yet it’s also an issue that requires a public consensus to support policies that might curb or counteract it. According to research, the task of educating the public about climate change might be made easier or more difficult depending on their perception of short-term versus long-term temperature changes.
Traumatized by the world's worst nuclear disaster since Chernobyl and encouraged by the highest rates for renewable energy in the world, Japan has been undergoing a green boom. It's now rapidly turning into a fiasco as the cost proves prohibitive and utilities anticipate putting some nuclear reactors back online. The utilities say they can't accommodate the flood of newcomers to the green energy business.
If the majority of light-duty vehicles in the U.S. ran on higher-octane gasoline, the automotive industry as a whole would reduce its carbon dioxide emissions by 35 million tons per year, saving up to $6 billion in fuel costs, according to a new analysis by Massachusetts Institute of Technology researchers.
U.S. health officials are recommending that people who are at highest risk for coming down with Ebola avoid commercial travel or attending large public gatherings, even if they have no symptoms. The Centers for Disease Control and Prevention issued the updated advice to state and local officials on Monday.
The governors of New York and New Jersey are at odds with scientists over Ebola as they back 21-day quarantines for medical workers returning from West Africa, while the nation's top infectious-disease expert warns that such restrictions are unnecessary and could discourage volunteers from aiding disease-ravaged countries.
- Page 1